Cancer News and Research

Latest Cancer News and Research

Lpath achieves one of the four Phase 1 objectives by demonstrating its optimized fermentation process

Lpath, Inc., the category leader in lipidomics-based therapeutics, demonstrated commercially acceptable yields in its optimized fermentation process. In doing so, Lpath achieved one of four Phase 1 objectives established by Merck Serono, the exclusive worldwide licensee of ASONEP and Lpath's development partner, and will receive a milestone payment according to the terms of the Merck Serono license agreement.

25 Aug 2009

Research reveals the life-long detrimental impact of maternal smoking during pregnancy

A new study by researchers at the Keck School of Medicine of the University of Southern California (USC) has found that the life-long effects of maternal smoking during pregnancy may occur through specific changes in DNA patterns.

25 Aug 2009

Senate Democrats plot new strategy, consider reconciliation to pass health bill

Senate Democrats are increasingly considering using budget reconciliation — which would need a simple majority of 51 votes — to pass health care reform without Republican support, The New York Times reports.

25 Aug 2009

Low-carbohydrate and high-protein diet increases the risk for atherosclerosis and impaired blood vessels

Even as low-carbohydrate/high-protein diets have proven successful at helping individuals rapidly lose weight, little is known about the diets' long-term effects on vascular health.

25 Aug 2009

New technique developed to identify gene copy number variations

A research team led by Associate Professor Jonathan Sebat, Ph.D., of Cold Spring Harbor Laboratory (CSHL) has developed a sensitive and accurate way of identifying gene copy number variations (CNVs).

25 Aug 2009

Avacor teams up with HopeCuts and Team Continuum to provide help for cancer patients

Avacor(R )Products LLC (http://www.avacor.com), a leading product line in the hair re-growth industry, has recently teamed up with two charitable organizations, HopeCuts, a division of City of Hope (http://www.cityofhope.org), and Team Continuum (http://www.teamcontinuum.net). Avacor((R)) is teaming up with both charities in an effort to help those fighting cancer as well as to help find new ways to fight this prolific disease.

25 Aug 2009

FDA clears Aperio Technologies to market breast tissue image analysis application

Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, has received clearance from the U.S. Food and Drug Administration (FDA) to market the IHC HER2 Breast Tissue Image Analysis application, available through its patented digital pathology platform.

25 Aug 2009

Elevated levels of GLI1 protein linked to unfavorable prognosis and progressive stages in human breast cancer

Elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein in human breast cancer are associated with unfavorable prognosis and progressive stages of disease. Researchers writing in the open access journal BMC Cancer found increased expression of GLI1 in samples taken from more advanced and less survivable tumors.

25 Aug 2009

Phase I/II trial of Amphinex uses photochemical internalisation approach

PCI Biotech Holding ASA, the Norwegian drug delivery company focusing on effective delivery of cancer therapeutics, today announced that the first patient has received treatment in the Phase I/II trial with the lead candidate Amphinex(R), which uses a new approach called photochemical internalisation.

25 Aug 2009

Accuracy reports 15 percent increase in total revenue in Q4 2009 results when compared to Q4 2008 fiscal

Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the fourth quarter and fiscal year 2009, ended June 27, 2009.

25 Aug 2009

Bioniche Life Sciences update on Phase III clinical program for evaluating Urocidin

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer.

24 Aug 2009

Concussions could result in permanent brain impairment

Concussions, whether from an accident, sporting event, or combat, can lead to permanent loss of higher level mental processes. Scientists have debated for centuries whether concussions involve structural damage to brain tissue or whether physiological changes that merely impair the way brain cells function, explain this loss.

24 Aug 2009

UAB researchers and information technology specialists win the caBIG- 2009 Deployment Award

A team of researchers and information technology specialists at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center has won the caBIG- 2009 Deployment Award from the National Cancer Institute (NCI).

24 Aug 2009

Health care profiles: Kennedy, Daschle and Kratovil

News reports this weekend explored some prominent personalities in health reform, as well as a new one. Sen. Edward Kennedy, D-Mass., continues to battle brain cancer at home, but his illness has taken on symbolic proportions in the debate.

24 Aug 2009

Rhode Island Hospital to identify a model for integrating screening and brief interventions for alcohol misuse

There are an estimated 7.6 million alcohol-related emergency department (ED) visits each year in the country. A first step in identifying an alcohol problem is screening all ED patients utilizing two well-researched screening tests.

24 Aug 2009

Orphan drug status granted to BioCancell's BC-819 drug

Tikcro Technologies today announced that the United States (“US”) Department of Health and Human Services ("HHS") has granted orphan drug status to BioCancell's BC-819 drug, currently in Phase I/IIa clinical trials, for its use in treating ovarian cancer.

24 Aug 2009

Santaris Pharma to discover and develop new RNA-based medicines for treating rare genetic disorders

Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced a multi-year worldwide strategic alliance with Shire plc to discover and develop new RNA-based medicines to treat rare genetic disorders.

24 Aug 2009

Aflac releases eighth new television commercial of 2009

Aflac today unveiled its eighth new television commercial of 2009, titled "Soccer." This commercial showcases the Aflac Duck as the web-footed star of the team, who helps provide a solid defense against unexpected medical bills. "Soccer" will debut on August 24, running nationally on CBS, ABC, FOX, NBC, CNN, CNBC, Discover Channel, USA, Headline News and the History Channel.

24 Aug 2009

Capital Earnings & Research to launch prostate cancer awareness campaign

What did all the following businessmen have in common?

24 Aug 2009

ARIAD's petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Federal Circuit

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and its co-plaintiffs today announced that the U.S. Court of Appeals for the Federal Circuit (the “Federal Circuit”) has granted their petition for rehearing en banc and has vacated its April 2009 decision in the appeal that Eli Lilly and Co. filed in 2008. All twelve judges of the Federal Circuit will now rehear and reassess the merits of Lilly’s appeal.

24 Aug 2009

Cancer News and Research

Latest Cancer News and Research

Lpath achieves one of the four Phase 1 objectives by demonstrating its optimized fermentation process

Research reveals the life-long detrimental impact of maternal smoking during pregnancy

Senate Democrats plot new strategy, consider reconciliation to pass health bill

Low-carbohydrate and high-protein diet increases the risk for atherosclerosis and impaired blood vessels

New technique developed to identify gene copy number variations

Avacor teams up with HopeCuts and Team Continuum to provide help for cancer patients

FDA clears Aperio Technologies to market breast tissue image analysis application

Elevated levels of GLI1 protein linked to unfavorable prognosis and progressive stages in human breast cancer

Phase I/II trial of Amphinex uses photochemical internalisation approach

Accuracy reports 15 percent increase in total revenue in Q4 2009 results when compared to Q4 2008 fiscal

Bioniche Life Sciences update on Phase III clinical program for evaluating Urocidin

Concussions could result in permanent brain impairment

UAB researchers and information technology specialists win the caBIG- 2009 Deployment Award

Health care profiles: Kennedy, Daschle and Kratovil

Rhode Island Hospital to identify a model for integrating screening and brief interventions for alcohol misuse

Orphan drug status granted to BioCancell's BC-819 drug

Santaris Pharma to discover and develop new RNA-based medicines for treating rare genetic disorders

Aflac releases eighth new television commercial of 2009

Capital Earnings & Research to launch prostate cancer awareness campaign

ARIAD's petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Federal Circuit

Industry Focus eBook - Oncology (1st Edition) eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in